19-45616495-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_012155.4(EML2):c.1475G>A(p.Gly492Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000563 in 1,597,814 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_012155.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EML2 | NM_012155.4 | c.1475G>A | p.Gly492Asp | missense_variant | 15/19 | ENST00000245925.8 | NP_036287.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EML2 | ENST00000245925.8 | c.1475G>A | p.Gly492Asp | missense_variant | 15/19 | 1 | NM_012155.4 | ENSP00000245925 | A1 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152038Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000327 AC: 8AN: 244808Hom.: 0 AF XY: 0.0000225 AC XY: 3AN XY: 133490
GnomAD4 exome AF: 0.00000553 AC: 8AN: 1445776Hom.: 0 Cov.: 31 AF XY: 0.00000279 AC XY: 2AN XY: 715772
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152038Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74254
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 01, 2024 | The c.2078G>A (p.G693D) alteration is located in exon 18 (coding exon 18) of the EML2 gene. This alteration results from a G to A substitution at nucleotide position 2078, causing the glycine (G) at amino acid position 693 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at